Abstract Previously, we reported that pyruvate production was markedly improved in TBLA-1, an H +
Introduction
L-Alanine is an important amino acid in terms of its applications in the pharmaceutical, food, and cosmetic industries (Leutenberger 1996) . Though it is largely produced for commercial use by chemical synthesis, various microbial approaches for alanine production exist. Alanine is the end product of glycolysis in some organisms (Chico et al. 1978; Örlygsson et al. 1995) , especially in thermophilic bacteria and archaea (Kengen and Stams 1994; Kobayashi et al. 1995; Ravot et al. 1996) . In addition, there are reports of alanine production directly from glucose. For example, Arthrobacter oxydans can produce alanine from glucose. Hashimoto and Katsumata isolated A. oxydans strain DAN 75 lacking alanine racemase, and this strain accumulated 75.6 g/l L-alanine in 120 h (Hashimoto and Katsumata 1998) .
Other means of alanine production have also been documented. Most Bacillus species produce alanine dehydrogenase (ADH), which they use for spore germination (Freese et al. 1964) . The introduction of this enzyme into another microorganism is a powerful approach in alanine production. Uhlenbusch et al. (1991) cloned the ADH gene from Bacillus sphaericus into Zymomonas mobilis, an ethanol producer, and reported that this strain produced 7.5 g/l alanine. Galkin et al. (1997) attempted to produce alanine in E. coli using the plasmid pFDHAlaDH, which contains the ADH gene from B. stearothermophilus and the formate dehydrogenase (FDH) gene from Mycobacterium vaccae. ADH utilizes pyruvate, NH were washed and transferred to fresh medium at pH 7.0. In comparison, in the alanine production system reported by Galkin et al. (1997) , pyruvate was added to the production medium as a substrate. Thus, these systems involved conversion rather than fermentation. Lee et al. (2004) reported the aerobic production of alanine by E. coli aceF (which encodes one of the pyruvate dehydrogenase complex genes) and ldhA (which encodes the fermentative lactate dehydrogenase [LDH] gene) mutants expressing the B. sphaericus ADH gene. In their report, E. coli was first grown under aerobic conditions and then was incubated under oxygen-limited conditions to induce alanine production. The cells were fed three times with glucose and NH 4 Cl, and 32 g/l alanine was produced from 100 g/l total glucose. In addition to these reports, lactic acid bacteria have also been used for alanine production (Hols et al. 1999) .
Unlike these studies, we attempted alanine fermentation under completely aerobic conditions in a single step using an H + -ATPase-defective mutant of E. coli. The sugar metabolism (both uptake and glycolytic flux) of this mutant is enhanced by its decreased cellular energy level (Yokota et al. 1997; Noda et al. 2006 ). An enhanced sugar metabolism is believed to be useful for improving fermentative production. For instance, E. coli TBLA-1, an H + -ATPasedefective mutant of the pyruvate-producing E. coli strain W1485lip2, showed increased pyruvate production (Yokota et al. 1994b ). Causey et al. (2004) also reported that a mutation in H + -ATPase stimulated pyruvate production in E. coli. In this study, we introduced two genetic alternations into the pyruvate-producing E. coli strain TBLA-1 to allow alanine fermentation. Alanine is synthesized from pyruvate, NH þ 4 , and NADH by ADH in a one-step reaction. In H + -ATPasedefective cells, the intracellular concentration of NADH, which is produced by glycolysis, is higher than in normal cells (Yokota et al. 1997; Noda et al. 2006) . Therefore, we introduced the ADH gene into TBLA-1 by transformation. LDH, which also uses NADH and pyruvate as substrates for lactate formation, seemed to compete with ADH for their common substrates. Thus, we also constructed a fermentative LDH gene (ldhA) knockout mutant of TBLA-1 to prevent lactate by-production (Fig. 1 ). Using these mutant strains, the direct production of alanine from glucose has been investigated in this study.
Materials and methods

Bacterial strains
E. coli W1485lip2 (ATCC25645; Herbert and Guest 1968) is a lipoic acid-requiring pyruvate producer (Yokota et al. 1994a ). An F 1 -ATPase-defective mutant, TBLA-1 (atpA401, bgl + ), was constructed by introducing a defective F 1 -ATPase gene, atpA401 (Butlin et al. 1971) , into W1485lip2 by P1 transduction (Yokota et al. 1994b) .
A defective LDH gene from a KO-collection strain, E. coli K-12 BW25113 ΔldhA, (Nara Institute of Science and Technology; Baba et al. 2006 ) was also introduced into TBLA-1 by P1 transduction.
Plasmid construction
The ADH gene of B. stearothermophilus was obtained from pFDHAlaDH (Galkin et al. 1997) by digesting the plasmid with SphI and EcoRI (i.e., at both ends of the ADH insert). Then, the ADH gene was ligated into the pUC19 vector (pMB1 replicon, high-copy number, i.e., >200 copies/cell). From this plasmid, the ADH insert was digested with HindIII and EcoRI and was cloned into the HindIII and EcoRI sites of the low-copy plasmids pSTV29 (p15A replicon, low-copy number, i.e., 10-12 copies/cell, TAKARA) and pHSG576 (pSC101 replicon, low-copy number, i.e., about 5 copies/ cell, National Institute of Genetics, Mishima, Japan).
PCR verification
E. coli K-12 BW25113 ΔldhA has a kanamycin-resistance gene in its chromosome at the ldhA position (Baba et al. 2006 Therefore, following P1 transduction, the ΔldhA mutant of TBLA-1 should have the kanamycin-resistance gene at the ldhA position. To verify the ldhA knockout, two-step PCR was performed using our candidate knockout strains. Five primers were used: kt (CGGCCACAGTCG ATGAATCC),
, and ldh-R (GCTGTTCTGGCGTAA CAGCA). At first, colony-direct PCR was done using primers kt and k2 to test for a 471-bp fragment of the kanamycinresistance gene. Subsequently, genomic PCR was performed to show that the mutants had the kanamycin-resistance gene at the correct position. The primers ldh-F and k1 were used to test for a 1,000-bp fragment, ldh-F and kt were used to test for a 1,500-bp fragment, and ldh-R and k2 were used to test for a 900-bp fragment. The thermal cycler parameters were as follows: 25 cycles of 30 s at 94°C, 10 s at 56°C, and 1 min at 72°C. The strain that gave amplified fragments of the appropriate lengths was selected for use as TBLA-1ΔldhA.
Culture conditions
The medium used for shaking-flask fermentation contained 20 g/l glucose, 4 g/l Polypepton (Nihon Pharmaceutical, Tokyo, Japan), 2 g/l NaCl, 10 g/l (NH 4 ) 2 SO 4 , 1 g/l K 2 HPO 4 , and 0.5 g/l MgSO 4 ·7H 2 O. The pH was adjusted to 8.0 with NaOH and sterilized at 120°C. Sterilized 20 g/l CaCO 3 , filter-sterilized 1 μg/l lipoic acid, 0.2 mM IPTG, and the appropriate antibiotics (50 mg/l ampicillin or chloramphenicol) for plasmid maintenance were also added to the medium before cultivation. The medium used for jar fermentation contained 50 g/l glucose, 4 g/l Polypepton (Nihon Pharmaceutical), 2 g/l NaCl, 10 g/l (NH 4 ) 2 SO 4 , 1 g/l K 2 HPO 4 , 0.5 g/l MgSO 4 ·7H 2 O, 14.7 mg/l CaCl 2 ·2H 2 O, and one drop of the antiforming agent Adekanol LG109 (ADEKA, Tokyo, Japan). The pH was adjusted to 8.0 using NaOH and sterilized at 120°C. Filtersterilized 1 μg/l lipoic acid, 0.5 mM IPTG, and antibiotics (50 mg/l chloramphenicol for all of the strains and 50 mg/l kanamycin for the ldh mutant strains) were also added. The medium used for the seed cultures was LB-glucose, including 2 g/l glucose and the appropriate antibiotics.
Culture method
All cultivations were carried out at 37°C. For shaking-flask fermentation, reciprocal shaker was set at 160 strokes/min with 4.5 cm amplitude. Fresh cells from LB-glucose agar plates were inoculated into 1 ml of LB-glucose and were cultured with shaking for 10 h. The entire culture broth was then transferred into 50 ml of LB-glucose in a flask and was cultured with shaking for 25 h.
Alanine fermentation
The preculture broth cultured for 12 h was inoculated into 1.2 l of fermentation medium to give an initial OD 660 of 0.07-0.08. The jar fermentor (BMJ-02PI, ABLE, Tokyo, Japan) was controlled at 600 rpm, 1 vvm aeration, 37°C, and pH 6.0 with a 1.2-l working volume in a 2-l reactor. The pH was kept at 6.0 using a 14% (w/v) ammonia solution to supply the ammonium ions needed for alanine production.
Measurement of enzymatic activity
The levels of ADH and LDH activity were measured in crude cell extracts. Cells were harvested by centrifugation and were washed twice with the appropriate buffer. After sonication, cell debris was removed by centrifugation at 18,000×g for 10 min at 4°C. The supernatant was used for the assays. The protein concentration in the cell extracts was determined by Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA), with bovine serum albumin as the standard.
The levels of ADH and LDH activity were analyzed by measuring the formation rate of alanine or lactate, respectively, through monitoring the decrease in NADH concentration at 340 nm (ɛ=6.22 M −1 cm −1 ) using a DU-7400 spectrophotometer (Beckmann, Fullerton, CA, USA). One unit of enzymatic activity was defined as the amount of enzyme required to produce a decrease in the level of NADH of 1 μmol/min. The reaction mixture for the ADH assay (1.0-ml total volume) consisted of 750 mM NH 4 OH/NH 4 Cl buffer (pH 9.0), 30 mM sodium pyruvate, and 0.1 mM NADH. The reaction mixture for the LDH assay consisted of 100 mM potassium phosphate buffer (pH 7.0), 30 mM sodium pyruvate, and 0.1 mM NADH in 1.0 ml of total volume. Both reactions were initiated by the addition of sodium pyruvate. ADH also needs NH þ 4 in addition to pyruvate and NADH as substrate; activity of ADH and LDH can be measured separately in this buffer system.
Identification of products and glucose consumption
The concentration of alanine in the culture supernatant was determined using a JLC-500S amino acid analyzer (JEOL, Tokyo, Japan). The levels of various organic acids were determined by HPLC using an L-7500 system (HITACHI, Tokyo, Japan) equipped with an AMINEX HPX-87 column (Bio-Rad) using 0.01 N H 2 SO 4 as the mobile phase (0.6 ml/min). The absorption at 210 nm was monitored to determine the organic acid concentrations. The concentration of glucose remaining in the culture broth was determined using a Glucose CII Test (Wako Pure Chemical Industries, Osaka, Japan).
Results
Construction of the ADH-expressing plasmid
W1485lip2 is a pyruvate producer with a wild-type H + -ATPase, whereas TBLA-1 is an isogenic strain from W1485lip2 with a leaky H + -ATPase. ADH activity of the host strains, both W1485lip2 and TBLA-1 without plasmid, was less than the detection limit (< 0.05 μmol min
protein). The ADH gene from B. stearothermophilus was cloned into the pUC19 vector and then transformed into TBLA-1 and W1485lip2; however, the resulting strain, TBLA-1/pUCADH, did not carry the plasmid stably. This may have resulted from the instability of a high-copynumber plasmid in an H + -ATPase-defective mutant. Thus, low-copy-number plasmids harboring the ADH gene (pSTVADH and pHSGADH) were also constructed. TBLA-1 was transformed by these plasmids to create TBLA-1/pUCADH, TBLA-1/pSTVADH, and TBLA-1/ pHSGADH. By measuring the growth, alanine production, and ADH activity of these strains (Table 1) , low-copynumber plasmid, pSTV29, was found to be the most suitable vector for expressing the ADH gene in an H + -ATPase-defective mutant.
As shown in Table 1 , ADH activity measured in vitro did not correlate with alanine productivity. In addition, alanine production in TBLA-1/pUCADH and TBLA-1/pHSGADH was neither stable nor reproducible (data not shown). Thus, we decided to use pSTVADH to introduce ADH gene into E. coli.
Effect of the mutation in H + -ATPase
As shown in Fig. 2a , the growth rate and the final cell density were higher in W1485lip2/pSTVADH than in TBLA-1/pSTVADH during cultures although the difference became much less than those observed in the corresponding parental strains under pyruvate production conditions as reported previously (Yokota et al. 1994b ). For example, the final cell density with the ancestor strain TBLA-1 without pSTVADH was much lower (the final OD 590 =5.7) than that of W1485lip2 without pSTVADH (the final OD 590 =8.5) during pyruvate fermentation (Yokota et al. 1994b) . It seemed that introduction of pSTVADH exhibited adverse effect on the growth of W1485lip2.
On the other hand, the glucose consumption rate was roughly the same in the two strains (Fig. 2b) . This result indicates that specific glucose consumption rate (glucose consumption rate per cell) by TBLA-1/pSTVADH was higher than that by W1485lip2/pSTVADH. In fact, all of the available glucose was consumed about after 24 h in both cultures (Fig. 2b) . It is interesting to note that the rate of glucose consumption was higher under ammonium ionexcess conditions (neutralizer; ammonia solution) than under ammonium ion-limited conditions (neutralizer; NaOH solution). For example, when NaOH was used as the neutralizer instead of the ammonia solution, the consumption of glucose by TBLA-1/pSTVADH was much slower (34 h). Alanine production was also remarkably increased as a result of using ammonia as the neutralizer. For example, 15 g/l alanine was produced under conditions of excess ammonium ions (Fig. 2c) , while 6 g/l alanine was produced by TBLA-1/pSTVADH under ammonium ionlimited conditions (data not shown in Fig. 2c , neutralizer; NaOH solution).
As shown in Fig. 2c , TBLA-1/pSTVADH produced 15 g/l alanine, while W1485lip2/pSTVADH, which contains a wild-type H + -ATPase, produced only 11 g/l alanine. As for the pyruvate to alanine conversion ratio, TBLA-1/ pSTVADH converted 56.9% of the pyruvate it produced to alanine, while W1485lip2/pSTVADH converted 43.8% (Table 2 ). These improvements may be a result of the H + -ATPase mutation.
Effect of the ldh mutation
The main by-products produced by the mutant (pyruvate, acetate, and lactate) are shown in Fig. 3 . A large amount of pyruvate, which is a substrate of ADH, was produced by the strains, suggesting that the conversion of pyruvate to alanine is a rate-limiting step in alanine production (Fig. 3a) . Acetate was also produced by all of the strains tested, but its yield was less than 5 g/l (Fig. 3b) . However, acetate production increased after the glucose in the medium was consumed (24 h). Alanine was produced during the consumption of glucose; thus, acetate production does not likely compete with alanine production. Consequently, lactate was the main competitor of alanine. TBLA-1/pSTVADH produced roughly 7.0 g/l lactate, which is a considerable amount (Fig. 3c) ; therefore, an ldh mutant version of TBLA-1/ pSTVADH was constructed to reduce lactate accumulation.
In the resulting strain, TBLA-1Δldh/pSTVADH, lactate production was almost negligible (Fig. 3c) while alanine production reached 20 g/l (Fig. 2c) . This result indicates that ldh mutation had been correctly introduced into TBLA-1, and more pyruvate was used for alanine production in TBLA-1Δldh/pSTVADH cells than in TBLA-1/pSTVADH cells. The molar conversion ratio of glucose to alanine was calculated to be 40.8% (Table 2) . Similarly, the conversion ratio of pyruvate to alanine was improved from 56.9% (TBLA-1/pSTVADH) to 60.7% (TBLA-1Δldh/pSTVADH).
Notably, TBLA-1Δldh/pSTVADH still produced a small amount of lactate after its glucose-consuming phase in spite of the ldh mutation (Fig. 3c) . This lactate was likely produced by some other means than fermentation by the ldhA-encoded LDH. However, the production of lactate seemed to have little effect on alanine production. Even in the best alanine producer in this study, the TBLA-1Δldh/ pSTVADH, which produced a large amount of pyruvate, the conversion ratio did not exceed 61% (Fig. 3a, Table 2 ).
Enzymatic activity of jar-fermented cells
The levels of ADH and LDH activity in the alanineproducing strains are given in Table 3 . These enzyme activities were measured using the cell from jar fermentor, and thus ADH activities of these strains were different from the data shown in Table 1 . TBLA-1/pSTVADH showed higher levels of ADH and LDH activity than W1485lip2/ pSTVADH. This result may be related to the alanine productivity of these strains. Strain TBLA-1Δldh/pSTVADH possessed no LDH activity, indicating that the ldh mutation had been introduced correctly. Even after 36 h of cultivation, TBLA-1Δldh/pSTVADH still showed a high level of ADH The data shown in Fig. 2 (after 24 h) were used for the calculations. Superscript letters "a" and "b" represent the molar conversion ratios. activity. This result indicates that the transformed plasmids were maintained in the cells even after long-term cultivation.
Discussion
Our results clearly indicate that the combination of an H + -ATPase defect with the ADH gene from another organism is effective for alanine production. The H + -ATPase-defective mutant, TBLA-1, produced 1.4-fold more alanine than its parental strain, W1485lip2. This improvement may be due to increased glucose consumption per cell by TBLA-1 as described previously (Yokota et al. 1994b; Noda et al. 2006) . In fact, glucose consumption rate per cell by TBLA-1/ pSTVADH seemed to be higher than that by W1485lip2/ pSTVADH (Fig. 2a,b) . Moreover, the conversion ratio of pyruvate to alanine in TBLA-1 was 13% higher than that in W1485lip2. To produce alanine via an ADH reaction, three substrates are needed: pyruvate, NH þ 4 , and NADH. A high concentration of pyruvate was still detected in the culture supernatant of both strains when excess ammonium ion was supplied to control the pH. Thus, NADH is a limiting factor in the conversion of pyruvate to alanine. Our results suggest that the intracellular concentration of NADH in TBLA-1/ pSTVADH was higher than that in W1485lip2/pSTVADH. Moreover, glucose consumption of TBLA-1/pSTVADH under ammonium-excess conditions was higher than that of TBLA-1/pSTVADH under ammonium-limited conditions. ADH can recycle the excess NADH formed by the enhanced central metabolism of TBLA-1, thus the alanine production by ADH may inhibit generation of an excessive protonmotive force, which inhibits cell growth (Noda et al. 2006) . This is the first report to show that an H + -ATPasedefective mutant of E. coli is useful for amino acid production. These results also indicate that an H + -ATPasedefective mutant may be used for the fermentative production of various compounds, including alanine.
As shown in Table 1 , ADH activity itself did not correlate to the alanine productivity. This result may indicate that the other factor other than ADH activity (i.e., intracellular concentration of NADH, NH þ 4 incorporation into the cell, etc.) are rate-limiting steps of alanine production using these strains.
Still, a considerable amount (about 7 g/l) of lactate was produced by TBLA-1/pSTVADH (Fig. 3c ). LDH competes with ADH for the substrates pyruvate and NADH; therefore, we added an ldh mutation to TBLA-1 to improve alanine production. Improved levels of alanine production have been shown in ldh knockouts in E. coli (Lee et al. 2004) and Lactococcus lactis (Hols et al. 1999) . Knocking out ldh was also effective in our system. Consequently, 1.3 times more alanine was produced by TBLA-1Δldh/ pSTVADH compared with TBLA-1/pSTVADH. In TBLA-1 Δldh/pSTVADH, the NADH consumed by LDH was used in the ADH-catalyzed reaction. This extra NADH may have improved the level of alanine production. In this strain, 41% (molar conversion ratio) of the consumed glucose was converted into alanine. To the best of our knowledge, this is the highest conversion ratio of glucose to alanine reported to date by fermentation, and it was achieved via simple batch culture without optimization of the growth conditions. Still, glucose feeding, aeration, pH, and the medium components seemed to play a role in controlling the yield of alanine.
In contrast, a large amount of pyruvate was still detected in all of the jar-fermented cultures, and the conversion ratio of pyruvate to alanine did not exceed 61% even for TBLA-1 Δldh/pSTVADH. ADH catalyzes a reversible reaction between pyruvate and alanine. It has been suggested that the reverse reaction (i.e., alanine to pyruvate) may inhibit further pyruvate conversion. This reverse reaction may be caused by a shortage of NADH or NH þ 4 . In TBLA-1, glycolysis was the major source of NADH, meaning that the supply of NADH was exhausted once the available glucose was entirely consumed. NH þ 4 was used to control the pH of the growth medium, thus it was supplied in excess during the log phase; however, this supply decreased at the stationary phase. To overcome this, additional glucose or ammonium ion, in the form of NH 4 Cl or (NH 4 ) 2 SO 4 , may be required during fermentation as reported by Lee et al. (2004) .
Additional mutations in the acetate pathway may also increase alanine productivity because a small amount of acetate was detected in the culture media during alanine production (Fig. 3b) . In TBLA-1, the activity of pyruvate dehydrogenase is strictly limited, thus the activity of phosphotransacetylase and acetate kinase, which produce acetate from acetyl-CoA, was not considered. In this strain, acetate was probably synthesized from pyruvate by pyruvate oxidase (Fig. 1) . Thus, mutation of this enzyme may promote additional alanine production. In fact, knocking out the E. coli pyruvate oxidase gene (PoxB) increases pyruvate pro- a Cells from the jar fermentor shown in Fig. 2 were used to measure the activity level.
duction (Causey et al. 2004) . Accordingly, PoxB would be a good candidate for mutation to improve the yield of alanine. This study recorded the highest conversion yield of alanine (to date) directly from glucose via microbial fermentation. In addition, this is the first report of alanine fermentation under totally aerobic conditions by E. coli. These results suggest that the combination of an energy-deficiency mutation with several other mutations can be useful for compound production.
